Enterprise Value
88.13M
Cash
192.9M
Avg Qtr Burn
-14.64M
Short % of Float
10.00%
Insider Ownership
0.71%
Institutional Own.
80.51%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
MRT-2359 Details Solid tumor/s, Non-small cell lung carcinoma | Phase 1/2 Update | |
MRT-6160 Details Inflammatory bowel disease | Phase 1 Data readout |